Home › Amgen ends partnership with AstraZeneca on inflammation drug
 

Keywords :   


Amgen ends partnership with AstraZeneca on inflammation drug

2015-05-23 01:30:34| Biotech - Topix.net

Amgen Inc said it will terminate a collaboration with AstraZeneca Plc to develop an inflammation drug after it observed suicidal thoughts in the subjects of a trial. AstraZeneca could decide on the development and marketing of the drug for all territories, except for Japan and certain Asian territories, where Kyowa Hakko Kirin has the rights to it, Amgen said.

Tags: drug partnership ends inflammation

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
08.11Nissan to lay off thousands of workers as sales drop
08.11Hurricane Rafael Graphics
08.11Hurricane Rafael Wind Speed Probabilities Number 18
08.11Hurricane Rafael Forecast Discussion Number 18
08.11Hurricane Rafael Forecast Advisory Number 18
08.11Hurricane Rafael Public Advisory Number 18
08.11Summary for Hurricane Rafael (AT3/AL182024)
08.11Up close with the 300 tonne driverless trucks
More »